The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice

Journal of Antimicrobial Chemotherapy

Volumn 30, Issue 3, 1992, Pages 339-348

  Mikasa, Keiichi ^a   Kita, Eiji ^a   Sawaki, Masayoshi ^a   Kunimatsu, Mikikazu ^a   Hamada, Kaoru ^a   Konishi, Mitsuru ^a   Kashiba, Shuzo ^a   Narita, Nobuhiro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; DEXAMETHASONE; ERYTHROMYCIN; PROSTAGLANDIN E2; ZYMOSAN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEUM EXUDATE; PERITONITIS; PLASMA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASCITIC FLUID; BLOOD PROTEINS; COMPARATIVE STUDY; DINOPROSTONE; DISEASE MODELS, ANIMAL; ERYTHROMYCIN; FEMALE; MICE; PERITONITIS; TIME FACTORS; TREATMENT FAILURE; ZYMOSAN;

EID: 0026768364     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/30.3.339     Document Type: Article

References (31)

1. Bonney, R. J., Wightman, P. D., Davies, P., Sadowslci, S. J., Kuehl, F. A. & Humes, J. L. (1978). Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases bymouse peritoneal macrophages. Biochemical Journal 176, 433-42.
2. Borel, J. F. (1973). Effects of some drugs on chemotaxis of rabbit neutrophils in vitro. Experientia 29, 676-8.
3. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry72, 248-54.
4. Doherty, N. S., Poubelle, P., Borgeat, P., Beaver, T. H., Westrich, G. L. & Schrader, N. L. (1985). Intraperitoneal injection of zymosan in mice induces pain, inflammation and thesynthesis of peptidoleukotrienes and prostaglandin Ej. Prostaglandins 30, 769-89.
5. Essner, R., Rhoades, K., McBride, W. H., Morton, D. L. & Economou, J. S. (1989). IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. Journal of Immunology 142, 3857-61.
6. Hart, P. H., Cooper, R. L. & Finlay-Jones, J. J. (1991). IL-4 suppresses IL-1/1, TNF-a and PGE2 production by human peritoneal macrophages. Immunology 72, 344-9.
7. Hart, P. H., Vitti, G. F., Burgess, D. R., Whitty, G. A., Piccoli, D. S. & Hamilton, J. A. (1989). Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumornecrosis factor a, interleukin 1, and prostaglandin Ej. Proceedings of the National Academyof Sciences of the USA 86, 3803-7.
8. Hudson, M. M., Markowitz, A. B., Gutterman, J. U., Knowles, R. D., Snyder, J. S. & Kleinerman, E. S. (1990). Effect of recombinant human interleukin 4 on human monocyteactivity. Cancer Research 50, 3154-8.
9. Humes, J. L., Sadowski, S., Galavage, M., Golden berg, M., Subers, E., Bonney, R. J. et al. (1982). Evidence for two sources of arachidonic acid for oxidative metabolism by mouseperitoneal macrophages. Journal of Biological Chemistry 257, 1591-4.
10. Janoff, A. (1985). Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. American Review of Respiratory Disease 132, 417-33.
11. Karlinsky, J. B. & Snider, G. L. (1978). Animal models of emphysema. American Review of Respiratory Disease 117, 1109-33.
12. Katahira, J. & Shimizu, K. (1988). Stimulatory effect of erythromycin on the proliferation and function of macrophage. (Abstract in Japanese) Igakunoayumi 147, 209-10.
13. Kelly, R. W., Graham, B. J. M. & O’Sullivan, M. J. (1989). Measurement of PGEj as the methyl oxime by radioimmunoassay using a novel iodinated label. Prostaglandins, Leukotrienes andEssential Fatty Acids 37, 187-91.
14. Kita, E., Sawaki, M., Nishikawa, F., Mikasa, K., Yagyu, Y., Takeuchi, S. et al. (1990). Enhanced interleukin production after long-term administration of erythromycin stearate.Pharmacology 41, 177-83.
15. Kita, E., Sawaki, M., Oku, D., Hamuro, A., Mikasa, K., Konishi, M. et al. (1991). Suppression of virulence factors of Pseudomonas aeruginosa by erythromycin. Journal of AntimicrobialChemotherapy 27, 273-84.
16. Lieberman, J. & Gawad, M. A. (1971). Inhibitors and activators of leukocytic proteases in purulent sputum. Digestion of human lung and inhibition of alpha,-antitrypsin. Journal ofLaboratory and Clinical Medicine 77, 713-27.
17. Lieberman, J. & Kaneshiro, W. (1972). Inhibition of leukocytic elastase from purulent sputum by alpha,-antitrypsin. Journal of Laboratory and Clinical Medicine 80, 88-101.
18. Maeom, Z. M. & Goswami, S. K. (1988). Erythromycin inhibits mucus secretion from human airways in vitro by affecting macrophage mucus secretagogue. American Review ofRespiratory Disease 137 (4 Pt 2), 6.
19. McBride, W. H., Economou, J. S., Nayersina, R., Comora, S. & Essner, R. (1990). Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclearphagocytes. Cancer Research 50, 2949-52.
20. Ohlsson, K. & Olsson, I. (1977). The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes. Scandinavian Journal of Haematology 19, 145-52.
21. Ohlsson, K. & Tegner, H. (1975). Granulocyte collagenase, elastase and plasma portease inhibitors in purulent sputum. European Journal of Clinical Investigation 5, 221-7.
22. Rivkin, I., Foschi, G. V. & Rosen, C. H. (1976). Inhibition of in vitro neutrophil chemotaxis and spontaneous motility by anti-inflammatory agents. Proceedings of the Society forExperimental Biology and Medicine 153, 236-40.
23. Sawaki, M., Mikami, R., Mikasa, K., Kunimatsu, M., Ito, S. & Narita, N. (1986). The long term chemotherapy with erythromycin in chronic lower respiratory tract infections. Secondreport: including cases with Pseudomonas infections. Kansenshogaku-Zasshi 60, 45-50.
24. Sawaki, M., Mikasa, K., Konishi, M., Hamada, K., Kunimatsu, M., Kita, E. & Narita, N. (1991). Efficacy of the long-term administration of erythromycin to chronic airway infectioncaused by Pseudomonas aeruginosa. In Abstracts of the Seventeenth International Conferenceof Chemotherapy, Berlin, 1991, Abstract 1867, International Society of Chemotherapy, Munich.
25. Scott, W. A., Zrike, J. M., Hamill, A. L., Kempe, J. & Cohn, Z. A. (1980). Regulation of arachidonic acid metabolites in macrophages. Journal of Experimental Medicine 152, 324-35.
26. Snider, G. L. (1981). The pathogenesis of emphysema-twenty years of progress. American Review of Respiratory Disease 124, 321-4.
27. Stockley, R. A. (1987). Bronchiectasis-new therapeutic approaches based on pathogenesis. Clinics in Chest Medicine 8, 481-94.
28. te Velde, A. A., Klomp, J. P. G., Yard, B. A., de Vries, J. E. & Figdor, C. G. (1988). Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4.Journal of Immunology 140, 1548-54.
29. Yamashita, T., Ishibashi, Y., Nagaoka, I., Kasuya, K., Masuda, K., Warabi, H. et al. (1982). Studies on glycogen-induced inflammation of mice. Dynamics of inflammatory responsesand influence of antiinflammatory drugs and protease inhibitors. Inflammation 6, 87-101.
30. Webster, G. F., Leyden, J. J., McGinley, K. J. & McArthur, W. P. (1982). Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterim acnes bysubminimal inhibitory concentrations of tetracycline, ampictllin, minocycline, anderythromycin. Antimicrobial Agents and Chemotherapy 21, 770-2.
31. Whittle, B. A. (1964). The use of changes in capillary permeability in mice to distinguish between narcotic and non-narcotic analgesics. British Journal of Pharmacology 22, 246-53.